Ketamine clinics are run by various provider types in the United States. In some states, mid-level practitioners (e.g., Nurse Practitioners and Physician Assistants) can practice independently. In other states, such providers can only work independently if they are supervised or overseen by a physician. However, the question then becomes whether any physician can run a
Time for another Oregon psilocybin licensing update. In this post we will explain what the Licensing Subcommittee covered in its recent meeting on March 3, 2022. Licensing Subcommittee Schedule and Timelines The Licensing Subcommittee meets every month to develop licensing requirements for psilocybin businesses and professionals. So far, it has developed recommendations regarding informed consent
Ketamine clinic providers engaged in the off label application of ketamine for patient treatment are nothing new in U.S. healthcare. What is relatively new is that many “psychedelics” companies are trying to infiltrate the ketamine clinic scene. These companies hope to gain a foothold, then expand into a fuller suite of psychedelic treatment services once
A synthetic substance with anesthetic and some psychedelic effects first synthesized in the 1960s. It was approved as an anesthetic by the U.S. Food and Drug Administration (in Ketalar, an intravenous drug). Ketamine was listed on Schedule III of the Controlled Substances Act in 1999.
A synthetic substance first synthesized in the 1960s similar to ketamine and is used for depression (in Spravato) and as an anesthetic (in Ketanest).
Ketamine is a Schedule III drug under the federal Controlled Substances Act (CSA). Physicians who dispense or administer it therefore must comply with a host of federal and state laws and regulations. This includes registering with the DEA at each location where the physician administers ketamine. But what about physicians who travel to a patient’s
I recently published a nationwide psychedelics law roundup post. But in doing so, I realized that it’s been a while since we did a comprehensive California psychedelics update. Today, I’ll walk through the two key proposed California psychedelics laws and where they stand. California’s push to decriminalize (almost) all psychedelics In 2021, California Senator Scott
Importing drug paraphernalia is illegal under the federal Controlled Substances Act (CSA). However, the expansive definition of “drug paraphernalia” can complicate the understanding of what items fit into this category. Federal agencies, particularly U.S. Customs and Border Protection (CBP), consider many factors when determining if a particular item is unlawful or not. Importers of psychedelic-related products need
Psychedelics developments in 2021 covered everything from legalization and decriminalization to pharmaceutical advances and public company milestones.
DMT, or N, N-dimethyltryptamine is a powerful psychedelic. DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back
